Physician profile
Benjamin Henkle
NPI 1669630083
$16,579.18
in general payments reported to CMS, 2019-2025
18 companies · $756 in 2025
The $756 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,158 · 2020: $1,043 · 2021: $1,492 · 2022: $4,995 · 2023: $6,096 · 2024: $1,039 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,972 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,145 · Travel and Lodging: $1,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,972.31 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,145.00 |
| Travel and Lodging | $1,773.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,696.74 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Ascenda |
| Abbott Laboratories | $2,121.00 | 2019-2025 | Proclaim, Octrode |
| Abbvie INC. | $1,348.59 | 2022-2025 | |
| Allergan, INC. | $790.70 | 2019-2022 | |
| Medtronic USA, INC. | $604.61 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $201.40 | 2019-2025 | Dysport |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Boston Scientific Corporation | $169.93 | 2019-2024 | |
| Tersera Therapeutics LLC | $100.48 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $96.82 | 2019-2021 | |
| Averitas Pharma INC. | $85.11 | 2024 | Qutenza |
| Si-Bone, INC. | $33.70 | 2024 | |
| Pfizer INC. | $33.30 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $27.81 | 2019 | |
| Vertos Medical, INC. | $24.40 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $24.31 | 2024 | Nalu Neurostimulation System |
| Relievant Medsystems, INC. | $21.68 | 2023 | Intracept |
| Biodelivery Sciences International, INC. | $18.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Henkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.